Daré Bioscience, Inc. (DARE) NASDAQ

2.97

+0.09(+3.13%)

Updated at May 30 04:00PM

Currency In USD

Valuation

Market Cap26.51M
Enterprise Value12.12M
P/E Ratio-15.52
PEG Ratio-0.24
Price/Sales Ratio2.68
Price/Book Ratio-2.72
Enterprise/Revenue1.99
Enterprise/EBITDA-0.89

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-0.17
Operating Margin-2.25

Management Effectiveness

Return On Assets-0.09
Return On Equity0.47

Income Statement

Revenue9,784
Revenue/Share1.12
Gross Profit9,784
EBITDA-3.54M
Net Income-4.05M
Diluted EPS-0.48

Balance Sheet

Total Cash10.33M
Total Cash/Share1.18
Total Debt3.57M
Total Debt/Equity-0.37
Current Ratio0.56
Book Value Per Share-1.09

Price History

52-Week Change-39.63
52-Week High6.24
52-Week Low2.67
Moving Average 50 Days2.91
Moving Average 200 Days3.24

Statistics

Average Volume17,947
Shares Outstanding8.85M
% Held by Institutions9.44

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:12
Last Split DateJuly 01, 2024